Charles River Laboratories | CRL - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.62M 133K 2026-03
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Cardinal Health USD 235M 1000K 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cigna USD 264.6M 1.14M 2026-03
Concord Medical Services Hldg CNY 130.25M 130.15M 2025-06
CVS Health USD 1.27B 2M 2026-03
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Elevance Health USD 217.37M 4.87M 2026-03
Humana USD 120.06M 529K 2026-03
Illumina USD 151.91M 893K 2026-03
Incyte USD 199.95M 1.49M 2026-03
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 166.9M 2.7M 2026-03
Laboratory Of America USD 82.3M 100K 2026-03
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Lonza CHF 68.64M 0 2025-12
McKesson USD 280M 156M 2025-12
Merck EUR 434.78M 0 2026-03
Mettler Toledo International USD 20.25M 179.94K 2026-03
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Quest Diagnostics USD 111M 1000K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
UnitedHealth USD 907.68M 1.84M 2026-03
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.17M 89K 2026-03
West Pharmaceutical Services USD 70.9M 1.1M 2026-03